Live Breaking News & Updates on உயிரியல் ப்ராடக்ட்|Page 3

Stay updated with breaking news from உயிரியல் ப்ராடக்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sinopharm COVID-19 vaccines appear safe, effective, study finds


Senate lawmakers pass a bill to declassify U.S. intelligence information regarding coronavirus and its origins
Two vaccines made by China’s Sinopharm appear safe and effective against COVID-19, according to a study published in a medical journal.
Scientists had been waiting for more details about the two vaccines, even though they already are being used in many countries, and one recently won the backing of the World Health Organization for emergency use.
The report, published online in the Journal of the American Medical Association, concluded the two vaccines are about 73% and 78% effective, as Sinopharm has previously claimed.
Researchers from Sinopharm and its local partners in the Middle East say the trial involved around 40,380 participants with the company s two vaccines one developed by the Wuhan Institute of Biological Products and the other by the Beijing Institute of Biological Products and a placebo. The trial was carried out in four countries B ....

United States , World Health Organization , Al Qahirah , United Arab Emirates , Jin Dong Yan , Wang Yi , Institute Of Biological Products , University Of Hong Kong , Institute Of Biological Product , Wuhan Institute Of Biological Products , Journal Of The American Medical Association , American Medical Association , Middle East , Wuhan Institute , Biological Products , Beijing Institute , Hong Kong , Biological Product , ஒன்றுபட்டது மாநிலங்களில் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஒன்றுபட்டது அரபு அமீரகங்கள் , ஜின் டாங் யான் , வாங் இ , நிறுவனம் ஆஃப் உயிரியல் ப்ராடக்ட்ஸ் , பல்கலைக்கழகம் ஆஃப் ஹாங் காங் , நிறுவனம் ஆஃப் உயிரியல் ப்ராடக்ட் ,

Coronavirus: Sinopharm COVID-19 vaccines appear safe, effective: study


Researchers from Sinopharm and its local partners in the Middle East say the trial involved around 40,380 participants with the company s two vaccines one developed by the Wuhan Institute of Biological Products and the other by the Beijing Institute of Biological Products and a placebo. The trial was carried out in four countries Bahrain, the United Arab Emirates, Egypt and Jordan. However, the study provided data for just Bahrain and the UAE.
There s nothing very surprising. It s consistent with what they have claimed previously, but it does not completely eliminate the doubts about Sinopharm, said Jin Dong-yan, a medical professor at the University of Hong Kong who was not involved with the study. ....

United States , World Health Organization , Al Qahirah , United Arab Emirates , Jakarta Raya , Jin Dong Yan , Wang Yi , Institute Of Biological Products , University Of Hong Kong , Institute Of Biological Product , Wuhan Institute Of Biological Products , Journal Of The American Medical Association , American Medical Association , Middle East , Wuhan Institute , Biological Products , Beijing Institute , Hong Kong , Biological Product , Covid 19 Canada , Anada Coronavirus , Uhan Virus , Uhan Coronavirus , Oronavirus Outbreak , Covid 19 , ஒன்றுபட்டது மாநிலங்களில் ,